Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaxCyte Share News (MXCT)

  • There is currently no data for MXCT

MaxCyte News

IN BRIEF: MaxCyte Signs APN401 Licensing Deal With Apeiron Biologics
8 Jul 2020

IN BRIEF: MaxCyte Signs APN401 Licensing Deal With Apeiron Biologics

IN BRIEF: MaxCyte Signs APN401 Licensing Deal With Apeiron Biologics

UK TRADING UPDATE SUMMARY: Filta Launches Covid-19 Sanitising Service
7 May 2020

UK TRADING UPDATE SUMMARY: Filta Launches Covid-19 Sanitising Service

UK TRADING UPDATE SUMMARY: Filta Launches Covid-19 Sanitising Service

MaxCyte Raises GBP25 Million To Fund Investments Ahead Of US IPO
1 May 2020

MaxCyte Raises GBP25 Million To Fund Investments Ahead Of US IPO

MaxCyte Raises GBP25 Million To Fund Investments Ahead Of US IPO

MaxCyte Annual Loss Widens As Carma Investment Increases
21 Apr 2020

MaxCyte Annual Loss Widens As Carma Investment Increases

MaxCyte Annual Loss Widens As Carma Investment Increases

UK TRADING UPDATE SUMMARY: Naked Wines, Distil Get Bar-Closure Boost
9 Apr 2020

UK TRADING UPDATE SUMMARY: Naked Wines, Distil Get Bar-Closure Boost

UK TRADING UPDATE SUMMARY: Naked Wines, Distil Get Bar-Closure Boost

MaxCyte to consolidate stock to single trading line
21 Feb 2020

MaxCyte to consolidate stock to single trading line

(Sharecast News) - Life sciences company MaxCyte announced the consolidation of its two lines of common stock into a single unrestricted line of commo...

MaxCyte 'exceptionally positive' following strong FY trading performance
20 Jan 2020

MaxCyte 'exceptionally positive' following strong FY trading performance

(Sharecast News) - Clinical-stage life sciences company MaxCyte told investors on Monday that its board was "exceptionally positive" of the group's fu...

MaxCyte Shares Rise As It Expects To Report 30% Increase In Revenue
20 Jan 2020

MaxCyte Shares Rise As It Expects To Report 30% Increase In Revenue

MaxCyte Shares Rise As It Expects To Report 30% Increase In Revenue